Navigation Links
Get New Patients, INC Releases New Infographic titled 'Are Negative Reviews Killing Your Medical Practice?"
Date:1/7/2013

takes 20 years to build a reputation and five minutes to ruin it. If you think about that, you'll do things differently."

Get New Patients, INC. in partnership with NorthStar SEO, LLC. educates the medical professional to be aware and protect themselves by understanding how to make this exposure work for them. Dreesen teaches how to address problems, making them opportunities to build relationships and reinforce recruitment of new patients. Besides teaching the medical professional how to access and monitor their reviews online, they offer their clients a full line of services to promote and protect their business. Get New Patients, INC. also suggests non-labor intensive short cuts that can be incorporated into the day to day running of the business that will allow the doctor and staff to monitor reviews, with minimum effort.

Get New Patients, INC. can be contacted in three ways, by phone at 888-221-0865, by email at info(at)getnewpatientsinc(dot)com or by visiting their website at http://www.getnewpatientsinc.com/contact/.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10276356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Author of the Uplifting Cancer Survival Guide, The C Card and Me, Opens Online Shop with Inspiring Gifts for Cancer Patients, Survivors and Caregivers
2. For Psychiatric Patients, Cancer Is Often Spotted Too Late
3. Traumatic brain injury patients, supercomputer simulations studied to improve helmets
4. For many prostate cancer patients, Web sites are too difficult to read
5. No July phenomenon for neurosurgery patients, reports Neurosurgery
6. Longer CPR attempts might benefit some patients, U-M research finds
7. Mayo study: Exercise can help cancer patients, but few oncologists suggest it
8. Individualized care best for lymphedema patients, MU researcher says
9. HIV drug reduces graft-vs.-host disease in bone marrow transplant patients, Penn study shows
10. Childs Scoliosis Stresses Patients, Parents: Study
11. Sleep improves functioning in Parkinsons patients, but reasons remain elusive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... of Hematology (ASH) will honor Michael DeBaun, MD, MPH, ... Hebbel, MD, of the University of Minnesota Medical School ... their significant research advances in the area of sickle ... the late Ernest Beutler, MD, a past president of ... a two-part lectureship that recognizes major translational advances related ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... on cholesterol treatment and cardiovascular risk assessment state that ... from atherosclerotic cardiovascular disease or of having a heart ... risk profile (based on age, smoking history, and cholesterol ... for when and how aggressively to treat high cholesterol ... Men,s Health , a peer-reviewed publication from Mary Ann ...
(Date:7/22/2014)... 22, 2014 The Entertainment Industries Council, ... resources, educational tools and recognition activities for thousands of ... prevention, treatment and recovery. On July 24, 2014, at ... some of these resources with a special mention of ... and treatment website at the end of the show. ...
(Date:7/22/2014)... --,High school lacrosse players are facing an increasing number ... new study finds. Although the most common injuries ... concussions, researchers report. They note a better understanding of ... ways to protect student athletes. "Concern over concussions ... to learn more about these injuries," said study co-author ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 3
... DALLAS, Nov. 21 Susan G. Komen for ... for breast cancer research and,community-based outreach programs, is ... students who lost a,parent to breast cancer., ... Scholarship Award helps students cover the costs of,tuition, ...
... Nov. 21 Inverness Medical,Innovations, Inc. (Amex: IMA ... offering on Tuesday. The Company sold a total,of 13,634,302 ... of $61.49,per share. The total number of shares sold ... upon their exercise of their,over-allotment option in full. Certain ...
... and often deadly among older American women, doctors too ... a new report by a team of vascular surgeons ... Medical College campuses of NewYork-Presbyterian Hospital. , Much of ... cardiovascular research has focused almost exclusively on males, so ...
... Genomic Health,Inc. (Nasdaq: GHDX ) today announced ... Executive Officer, will present at the Piper,Jaffray Health ... 28, 2007 at 1:00,p.m. Eastern Time., To ... the,presentation, visit the Investor Relations section of Genomic ...
... Ore., Nov. 21 ,Danaher Corporation (NYSE: DHR ) ... the expiration, as of 11:59 PM, New York City ... in the tender offer,made by Raven Acquisition Corp., Danaher,s ... of Tektronix, Inc. common,stock. The initial tender offer period ...
... plans that give best value for money, study finds , ... aren,t implementing strategies and programs to improve the quality and ... in the Nov. 21 issue of the Journal of ... Health researchers surveyed 609 executives of the largest employers ...
Cached Medicine News:Health News:Susan G. Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 2Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2Health News:Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares 2Health News:Most U.S. Companies Do Little to Boost Worker Health Benefits 2
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), ... focused on commercialization of its non-invasive Monarch ... and neuropsychiatric disorders, today announced that enrollment has begun ... nerve stimulation (eTNS) as adjunctive therapy for the treatment ... being conducted at the Olive View-UCLA Medical Center in ...
(Date:7/22/2014)... York , July 22, 2014 ... Partnerschaft für umfassenden Schutz von Pharmazeuten ... Österreich    Equashield ( ... Transfersystemen (Closed System Transfer Devices, CSTDs) für gefährliche ... einen Vertriebshändler und Hersteller von medizinischen ...
(Date:7/21/2014)... McCord Research, Inc. was recently granted ... This patent describes a method for accelerating wound ... inventor, Dr. McCord, this method includes administering or ... composition of an effective amount of hydroxytyrosol and ... such that the administration of the combination reduces ...
Breaking Medicine Technology:Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2
... well-tolerated with signs of durable,disease control in advanced ... /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented preliminary results ... trial (DC-MEL-202). The,results showed that UVIDEM was well ... response in patients with,progressive metastatic melanoma. , The ...
... trial presented at ENDO 2007 , ,- Regulatory approvals ... recruitment in Europe , ,MONTREAL, QUEBEC -- (MARKET WIRE) ... that 26-week data from,its first Phase 3 study testing ... ENDO, the 89th,annual meeting of the Endocrine Society. The ...
Cached Medicine Technology:IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3
... practical, comfortable chair for examination ... height is adjustable from 540 ... use of an independent foot ... through 360 and incorporates a ...
... Halogen HPX Streak Retinoscope ... handle and provides 40% ... conventional scopes and maintains ... which greatly enhances illumination ...
Sandown chair, with hydraulic lift, sliding headrest and armrests with glides. Black vinyl....
3.5v Halogen HPX Spot Retinoscope provides 40% more light output than conventional scopes and maintains a consistent output level which greatly enhances illumination and produces the sharpest retina...
Medicine Products: